Watch this company for free updates
Simply enter your email address below and we will send you an email when the company files any documents or there is a change to their credit report.
We require your email address in order to send you alerts by email. You can unsubscribe at any time.
Thank you, you are now watching this company.
You will receive email updates when this company's information changes.
You can choose which alerts you receive and can unsubscribe at any time.
Unlock CANCER RESEARCH TECHNOLOGY LIMITED's Credit Report?
Unlock The Full Report
- Credit score, financials and risk data
- Directors, shareholders and ownership
- CCJs, payment behaviour and filing history
- 5 official Companies House documents
- Instant download and online viewing
- Email alerts for key changes
- Personal monitoring dashboard
Upgrade to Lite
- 5 credit reports
- 100 accounts downloads
- 100 accounts exports
Your plan will start immediately and the time remaining on your existing plan will be refunded
Yes, upgrade to LiteCANCER RESEARCH TECHNOLOGY LIMITED
2 REDMAN PLACE, LONDON, E20 1JQ
Buy Report - £20
Download PDF
Unlock the Full Company Report
- ✓ Check whether this company is legitimate
- ✓ See if this company is likely to run into financial trouble
- ✓ Find out who owns and runs the company
- ✓ Avoid risky business relationships
- ✓ Get instant updates if anything important changes
- ✓ Access official company documents for free
CANCER RESEARCH TECHNOLOGY LIMITED
Private limited with Share Capital
Active - Accounts Filed
31 March 1982
72110 Research and experimental development on biotechnology - Research and experimental development on biotechnology
Available to 26 Jul 2025. Next accounts due by 31 Dec 2026
Is CANCER RESEARCH TECHNOLOGY LIMITED in debt to you?
Don't write it off. As exclusively featured on Can't Pay? We'll Take It Away!, DCBL provides a nationwide service recovering over £85 million annually.
Our unique "One Solution" works seamlessly with DCB Legal, managing debt recovery from the first letter through to High Court enforcement.
We act fast to protect your cash flow and recover what you're owed. Recover your debt with the UK's experts.
Current Directors & Secretaries
For a full in-depth analysis on each of these directors, click any of the links below
| Name | Role | Date Of Birth | Appointed |
|---|---|---|---|
| Dr Heather Elizabeth Preston | Director | ||
| Dr Richard Francis Wooster | Director | ||
| Mr Hans Edgar Bishop | Director | ||
| Mr Hitesh Thakrar | Director | ||
| Ms Anna Lisa Mary Jenkins | Director | ||
| Mr Christoph Lengauer | Director | ||
| Ms Gillian Amanda Fairfield | Company Secretary | ||
| Mr Parker David Moss | Director | ||
| Mr Anthony Charles Hickson | Director | ||
| Dr Iain Walter Foulkes | Director | ||
| Mr Peter Alan Chambre | Director |
Previous Directors & Secretaries
Mortgages and Charges
Total Outstanding
1
Total Satisfied
0
| Type | Created | Registered | Persons Entitled | Status |
|---|---|---|---|---|
| Floating Charge | Cancer Research Uk | OUTSTANDING |
Key Financials
| Accounts | |||||
|---|---|---|---|---|---|
| Cash | £1,613,000.00 | £2,359,000.00 | £1,153,000.00 | £2,593,000.00 | £2,527,000.00 |
| Net Worth | £16,078,000.00 | £23,902,000.00 | £12,473,000.00 | £20,305,000.00 | £19,375,000.00 |
| Total Current Liabilities | £18,700,000.00 | £22,992,000.00 | £58,888,000.00 | £86,362,000.00 | £88,020,000.00 |
| Total Current Assets | £30,681,000.00 | £42,592,000.00 | £68,015,000.00 | £97,071,000.00 | £100,397,000.00 |
Frequently Asked Questions about CANCER RESEARCH TECHNOLOGY LIMITED
Detailed answers about CANCER RESEARCH TECHNOLOGY LIMITED, including incorporation, status, business activity, and accounts information.
When was CANCER RESEARCH TECHNOLOGY LIMITED founded?
CANCER RESEARCH TECHNOLOGY LIMITED was officially incorporated on 31 March 1982 and is registered under company number 01626049. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is CANCER RESEARCH TECHNOLOGY LIMITED?
Private limited with Share Capital. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. For example, a private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of CANCER RESEARCH TECHNOLOGY LIMITED?
CANCER RESEARCH TECHNOLOGY LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does CANCER RESEARCH TECHNOLOGY LIMITED do?
CANCER RESEARCH TECHNOLOGY LIMITED operates in the following sector: 72110 Research and experimental development on biotechnology - Research and experimental development on biotechnology . This provides insight into the company’s primary business activities and industry focus. Knowing the SIC code and description is useful for market research, assessing competitors, and understanding potential business risks.
What is CANCER RESEARCH TECHNOLOGY LIMITED's registered address?
The registered office address of CANCER RESEARCH TECHNOLOGY LIMITED is 2, Redman Place, London, Newham, E20 1JQ. This is the official address filed with Companies House for legal and statutory correspondence.
Is CANCER RESEARCH TECHNOLOGY LIMITED financially stable?
Based on the latest accounts up to 26 Jul 2025, CANCER RESEARCH TECHNOLOGY LIMITED has filed financial statements showing its assets, liabilities, and overall trading performance. The next accounts are due by 31 Dec 2026. Reviewing these accounts helps assess the company’s financial stability, creditworthiness, and risk profile, which is crucial for investors, suppliers, and potential business partners.